IAN T. BOTHWELL - 04 Jun 2021 Form 4 Insider Report for Organicell Regenerative Medicine, Inc. (OCEL)

Role
Chief Financial Officer, Director, 10%+ Owner
Signature
/s/ Ian Bothwell
Issuer symbol
OCEL
Transactions as of
04 Jun 2021
Net transactions value
-$40,508
Form type
4
Filing time
08 Jun 2021, 21:46:33 UTC
Previous filing
03 Jun 2021
Next filing
11 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCEL Common Stock Sale $7,000 -50,000 -0.03% $0.1400 148,788,726 04 Jun 2021 Direct
transaction OCEL Common Stock Sale $6,321 -46,136 -0.03% $0.1370 148,742,590 04 Jun 2021 Direct
transaction OCEL Common Stock Sale $537 -3,864 -0% $0.1390 148,738,726 04 Jun 2021 Direct
transaction OCEL Common Stock Sale $6,150 -50,000 -0.03% $0.1230 148,688,726 07 Jun 2021 Direct
transaction OCEL Common Stock Sale $6,200 -50,000 -0.03% $0.1240 148,638,726 07 Jun 2021 Direct
transaction OCEL Common Stock Sale $7,150 -50,000 -0.03% $0.1430 148,588,726 08 Jun 2021 Direct
transaction OCEL Common Stock Sale $7,150 -50,000 -0.03% $0.1430 148,538,726 08 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.